Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Performance of Positron Emission Tomography at Diagnosis and Response Assessment in Low and Intermediate-Risk Nodular Lymphocyte Predominant Hodgkin Lymphoma

Lianna J. Marks, Kathleen McCarten, Qinglin Pei, Yue Wu, Kara M. Kelly, Cindy Schwartz, Suzanne Wolden, Debra L. Friedman, Sharon M. Castellino, Burton Appel

Blood (2023) 142 (Supplement 1): 1699.

https://doi.org/10.1182/blood-2023-179465

Published: 2023

Journal Articles

Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031

Lisa Giulino-Roth, MD, Qinglin Pei, PhD, Allen Buxton, MS, Suzanne Wolden, MD, Louis S. Constine, MD, Kara M. Kelly, MD, Cindy L. Schwartz, MD MPH, Debra L. Friedman, MD MS

Blood (2016) 128 (22): 924.

https://doi.org/10.1182/blood.V128.22.924.924

Published: 2016

Journal Articles

T- Cell Depleted Peripheral Blood Stem Cell (TCD-PBSC) Transplants Secure Consistent Engraftment with Low Risk of Acute or Chronic Gvhd and Favorable Disease Free Survival (DFS) and Overall Survival (OS) for Pediatric Patients (<21 years) with AML in CR1 or CR2 or MDS Including tMDS/AML

Nancy A. Kernan, MD, Farid Boulad, MD, Susan Prockop, MD, Suzanne Wolden, MD, Andromachi Scaradavou, MD, Rachel Kobos, Rachel Lehrman, Elizabeth Klein, MPH, Kevin J. Curran, MD, Aisha N Hasan, MD, Sharon Bleau, Julianne Ruggiero, PNP, Nicole Zakak, PNP, Anne Casson, PNP, Joanne Torok-Castanza, PNP, Richard J O'Reilly, MD

Blood (2015) 126 (23): 5513.

https://doi.org/10.1182/blood.V126.23.5513.5513

Published: 2015

Journal Articles

The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma,

Cindy Schwartz, MD, MPH, Lu Chen, PhD, Louis Constine, MD, Suzanne Wolden, Frank G Keller, MD, Kara M Kelly, MD, Debra l Friedman, MD, MS

Blood (2011) 118 (21): 3649.

https://doi.org/10.1182/blood.V118.21.3649.3649

Published: 2011

Journal Articles

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Debra l Friedman, MD, MS, Suzanne Wolden, Louis Constine, MD, Lu Chen, PhD, Kathleen M McCarten, MD, T. J Fitzgerald, Pedro De Alarcon, MD, Allen R. Chen, MD, PhD, MHS, Robert Hutchison, MD, Peter Ehrlich, Nathan L. Kobrinsky, MD, FRCP, Meghan Higman, Shirley Hogan, Lorna Roll, Tanya Trippett, Cindy Schwartz, MD

Blood (2010) 116 (21): 766.

https://doi.org/10.1182/blood.V116.21.766.766

Published: 2010

NARROW

Performance of Positron Emission Tomography at Diagnosis and Response Assessment in Low and Intermediate-Risk Nodular Lymphocyte Predominant Hodgkin Lymphoma

Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031

T- Cell Depleted Peripheral Blood Stem Cell (TCD-PBSC) Transplants Secure Consistent Engraftment with Low Risk of Acute or Chronic Gvhd and Favorable Disease Free Survival (DFS) and Overall Survival (OS) for Pediatric Patients (<21 years) with AML in CR1 or CR2 or MDS Including tMDS/AML

The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma,

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Email alerts

ASH Publications

American Society of Hematology

Performance of Positron Emission Tomography at Diagnosis and Response Assessment in Low and Intermediate-Risk Nodular Lymphocyte Predominant Hodgkin Lymphoma

Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031

T- Cell Depleted Peripheral Blood Stem Cell (TCD-PBSC) Transplants Secure Consistent Engraftment with Low Risk of Acute or Chronic Gvhd and Favorable Disease Free Survival (DFS) and Overall Survival (OS) for Pediatric Patients (<21 years) with AML in CR1 or CR2 or MDS Including tMDS/AML

The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma,

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only